tiprankstipranks
Advertisement
Advertisement
Castle Biosciences’ i31-SLNB outperforms MIA nomogram in lymph node biopsy
PremiumThe FlyCastle Biosciences’ i31-SLNB outperforms MIA nomogram in lymph node biopsy
1M ago
Roth starts Castle Biosciences at Buy, notes quality revenue growth outlook
Premium
The Fly
Roth starts Castle Biosciences at Buy, notes quality revenue growth outlook
1M ago
Castle Biosciences initiated with a Buy at Roth Capital
Premium
The Fly
Castle Biosciences initiated with a Buy at Roth Capital
1M ago
Castle Biosciences price target lowered to $40 from $50 at BTIG
PremiumThe FlyCastle Biosciences price target lowered to $40 from $50 at BTIG
3M ago
Castle Biosciences: Buy Reiterated on Strong Q1 Execution and Undervalued Growth Potential Despite Price Target Trim to $40
Premium
Ratings
Castle Biosciences: Buy Reiterated on Strong Q1 Execution and Undervalued Growth Potential Despite Price Target Trim to $40
3M ago
Castle Biosciences Lifts 2026 Guidance Amid Test Surge
Premium
Company Announcements
Castle Biosciences Lifts 2026 Guidance Amid Test Surge
3M ago
Castle Biosciences Posts Strong Q1 Results, Raises 2026 Guidance
PremiumCompany AnnouncementsCastle Biosciences Posts Strong Q1 Results, Raises 2026 Guidance
3M ago
Castle Biosciences price target lowered to $40 from $50 at Canaccord
Premium
The Fly
Castle Biosciences price target lowered to $40 from $50 at Canaccord
3M ago
Castle Biosciences to present new data from DecisionDx-Melanoma test at AAD
Premium
The Fly
Castle Biosciences to present new data from DecisionDx-Melanoma test at AAD
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100